
TY  - JOUR
AU  - Rahman
AU  - Hodgson
TI  - Review article: liver support systems in acute hepatic failure
JO  - Alimentary Pharmacology & Therapeutics
VL  - 13
IS  - 10
SN  - 0269-2813
UR  - https://doi.org/10.1046/j.1365-2036.1999.00597.x
DO  - doi:10.1046/j.1365-2036.1999.00597.x
SP  - 1255
EP  - 1272
PY  - 1999
AB  - The treatment of acute hepatic failure has developed rapidly over the last 40 years, reducing morbidity and mortality from this syndrome. Whilst this has been partly attributed to significant improvements in the specialist medical management of these patients, advances in surgical techniques and pharmaceutical developments have led to the establishment of successful liver transplantation programmes, which have improved mortality significantly. This review will examine the clinical impact of alternative methods that have been used to provide extra-corporeal hepatic support. Non-biological, bio- logical and hybrid hepatic extra-corporeal support will be explored, offering a comprehensive historical overview and an appraisal of present and future advances.
ER  - 

TY  - JOUR
TI  - Poster Sessions
JO  - Immunology
VL  - 137
IS  - s1
SN  - 0019-2805
UR  - https://doi.org/10.1111/imm.12002
DO  - doi:10.1111/imm.12002
SP  - 185
EP  - 772
PY  - 2012
ER  - 

TY  - JOUR
TI  - Thursday, 28 July 2011
JO  - Journal of Thrombosis and Haemostasis
VL  - 9
IS  - s2
SN  - 1538-7933
UR  - https://doi.org/10.1111/j.1538-7836.2011.04380_4.x
DO  - doi:10.1111/j.1538-7836.2011.04380_4.x
SP  - 712
EP  - 959
PY  - 2011
ER  - 

TY  - JOUR
TI  - Program Overview
JO  - Arthritis & Rheumatism
JA  - Arthritis & Rheumatism
VL  - 39
IS  - S9
SN  - 0004-3591
UR  - https://doi.org/10.1002/art.1780391402
DO  - doi:10.1002/art.1780391402
SP  - S27
EP  - S325
PY  - 1996
ER  - 

TY  - JOUR
TI  - Monday, 25 July 2011
JO  - Journal of Thrombosis and Haemostasis
VL  - 9
IS  - s2
SN  - 1538-7933
UR  - https://doi.org/10.1111/j.1538-7836.2011.04380_1.x
DO  - doi:10.1111/j.1538-7836.2011.04380_1.x
SP  - 1
EP  - 250
PY  - 2011
ER  - 

TY  - JOUR
TI  - 46th Annual Meeting of the Arbeitsgemeinschaft Dermatologische Forschung (ADF)
JO  - Experimental Dermatology
JA  - Exp Dermatol
VL  - 28
IS  - 3
SN  - 0906-6705
UR  - https://doi.org/10.1111/exd.13859
DO  - doi:10.1111/exd.13859
SP  - e1
EP  - e122
PY  - 2019
ER  - 

TY  - JOUR
TI  - Poster Absracts
JO  - Vox Sanguinis
JA  - Vox Sang
VL  - 107
IS  - s1
SN  - 0042-9007
UR  - https://doi.org/10.1111/vox.12155
DO  - doi:10.1111/vox.12155
SP  - 57
EP  - 248
PY  - 2014
ER  - 

TY  - JOUR
TI  - Scientific
JO  - Transfusion
VL  - 46
IS  - 9s
SN  - 0041-1132
UR  - https://doi.org/10.1111/j.1537-2995.2006.01023_1.x
DO  - doi:10.1111/j.1537-2995.2006.01023_1.x
SP  - 1A
EP  - 164A
PY  - 2006
ER  - 

TY  - JOUR
TI  - ORAL COMMUNICATIONS
JO  - British Journal of Pharmacology
VL  - 114
IS  - S1
SN  - 0007-1188
UR  - https://doi.org/10.1111/j.1476-5381.1995.tb16306.x
DO  - doi:10.1111/j.1476-5381.1995.tb16306.x
SP  - 1P
EP  - 175P
PY  - 1995
ER  - 

TY  - JOUR
TI  - Administrative Operations
JO  - Transfusion
VL  - 46
IS  - 9s
SN  - 0041-1132
UR  - https://doi.org/10.1111/j.1537-2995.2006.01023_2.x
DO  - doi:10.1111/j.1537-2995.2006.01023_2.x
SP  - 165A
EP  - 233A
PY  - 2006
ER  - 

TY  - JOUR
TI  - Abstracts
JO  - International Journal of Stroke
VL  - 3
IS  - s1
SN  - 1747-4930
UR  - https://doi.org/10.1111/j.1747-4949.2008.00231.x
DO  - doi:10.1111/j.1747-4949.2008.00231.x
SP  - 2
EP  - 474
PY  - 2008
ER  - 

TY  - JOUR
TI  - Abstract Supplement 2019 ACR/ARP Annual Meeting
JO  - Arthritis & Rheumatology
JA  - Arthritis Rheumatol
VL  - 71
IS  - S10
SN  - 2326-5191
UR  - https://doi.org/10.1002/art.41108
DO  - doi:10.1002/art.41108
SP  - 1
EP  - 5420
PY  - 2019
AB  - Abstract For a searchable version of these abstracts, please visit www.acrabstracts.org.
ER  - 

TY  - JOUR
TI  - Oral Presentations
JO  - Transplant International
JA  - Transpl Int
VL  - 30
IS  - S2
SN  - 0934-0874
UR  - https://doi.org/10.1111/tri.13051
DO  - doi:10.1111/tri.13051
SP  - 8
EP  - 164
PY  - 2017
ER  - 

TY  - JOUR
AU  - Cheng, Ni
AU  - Liang, Yurong
AU  - Du, Xiaoping
AU  - Ye, Richard D
C7  - e45517
TI  - Serum amyloid A promotes LPS clearance and suppresses LPS-induced inflammation and tissue injury
JO  - EMBO reports
JA  - EMBO rep
VL  - 19
IS  - 10
SN  - 1469-221X
UR  - https://doi.org/10.15252/embr.201745517
DO  - doi:10.15252/embr.201745517
SP  - e45517
KW  - acute-phase response
KW  - inflammation
KW  - innate immunity
KW  - lipopolysaccharide
KW  - serum amyloid A
PY  - 2018
AB  - Abstract Lipopolysaccharide (LPS) is a major microbial mediator for tissue injury and sepsis resulting from Gram-negative bacterial infection. LPS is an external factor that induces robust expression of serum amyloid A (SAA), a major constituent of the acute-phase proteins, but the relationship between SAA expression and LPS-induced tissue injury remains unclear. Here, we report that mice with inducible transgenic expression of human SAA1 are partially protected against inflammatory response and lung injury caused by LPS and cecal ligation and puncture (CLP). In comparison, transgenic SAA1 does not attenuate TNFα-induced lung inflammation and injury. The SAA1 expression level correlates inversely with the endotoxin concentrations in serum and lung tissues since SAA1 binds directly to LPS to form a complex that promotes LPS uptake by macrophages. Disruption of the SAA1-LPS interaction with a SAA1-derived peptide partially reduces the protective effect and exacerbates inflammation. These findings demonstrate that acute-phase SAA provides innate feedback protection against LPS-induced inflammation and tissue injury.
ER  - 

TY  - JOUR
TI  - Abstracts for the Joint Meeting
JO  - Artificial Organs
VL  - 17
IS  - 6
SN  - 0160-564X
UR  - https://doi.org/10.1111/j.1525-1594.1993.tb00440.x
DO  - doi:10.1111/j.1525-1594.1993.tb00440.x
SP  - 450
EP  - 576
PY  - 1993
ER  - 

TY  - JOUR
TI  - AASLD Abstracts
JO  - Hepatology
JA  - Hepatology
VL  - 58
IS  - S1
SN  - 0270-9139
UR  - https://doi.org/10.1002/hep.26727
DO  - doi:10.1002/hep.26727
SP  - 208A
EP  - 1309A
PY  - 2013
ER  - 

TY  - JOUR
TI  - Tissue Engineering and Regenerative Medicine
JO  - Journal of Tissue Engineering and Regenerative Medicine
VL  - 6
IS  - s1
SN  - 1932-6254
UR  - https://doi.org/10.1002/term.1586
DO  - doi:10.1002/term.1586
SP  - 1
EP  - 429
PY  - 2012
ER  - 

TY  - JOUR
TI  - Abstracts of ICI 2016 International Congress of Immunology, 21–26 August 2016, Melbourne, Australia
JO  - European Journal of Immunology
JA  - Eur. J. Immunol.
VL  - 46
IS  - S1
SN  - 0014-2980
UR  - https://doi.org/10.1002/eji.201670200
DO  - doi:10.1002/eji.201670200
SP  - 1
EP  - 1274
PY  - 2016
ER  - 

TY  - JOUR
AU  - Xie, Hongxiang
AU  - Sheng, Liangju
AU  - Zhou, Hong
AU  - Yan, Jinchuan
TI  - The role of TLR4 in pathophysiology of antiphospholipid syndrome-associated thrombosis and pregnancy morbidity
JO  - British Journal of Haematology
JA  - Br J Haematol
VL  - 164
IS  - 2
SN  - 0007-1048
UR  - https://doi.org/10.1111/bjh.12587
DO  - doi:10.1111/bjh.12587
SP  - 165
EP  - 176
KW  - antiphospholipid syndrome
KW  - toll-like receptor 4
KW  - beta-2 glycoprotein I
KW  - nuclear factor-κB
KW  - coagulation factor III (tissue factor)
PY  - 2014
AB  - Summary The antiphospholipid syndrome (APS) is an autoimmune disease characterized by the clinical features of recurrent thrombosis in the venous or arterial circulation and fetal losses. Antiphospholipid antibodies (aPL), particularly against the phospholipid binding protein beta-2 glycoprotein I (?2GPI), play an important role in APS pathological mechanisms. aPL can activate intracellular signal transduction in a ?2GPI-dependent manner to induce inflammatory responses, and promote hypercoagulable state and recurrent spontaneous abortion when ?2GPI is associated with the cell surface receptor. In vivo and in vitro studies show that Annexin A2 (ANXA2) is the high affinity receptor that connects ?2GPI to the target cells. However, ANXA2 is not a transmembrane protein and lacks an intracellular signal transduction pathway. Growing evidences suggest that the transmembrane protein toll-like receptor 4 (TLR4) might act as an ?adaptor? for intracellular signal transduction. This review focuses on the role of TLR4 and its signalling pathway in APS pathological mechanisms which will help us better understand the pathological processes of this syndrome.
ER  - 

TY  - JOUR
TI  - Poster Sessions
JO  - American Journal of Transplantation
JA  - American Journal of Transplantation
VL  - 13
IS  - S5
SN  - 1600-6135
UR  - https://doi.org/10.1111/ajt.12266
DO  - doi:10.1111/ajt.12266
SP  - 207
EP  - 554
PY  - 2013
AB  - First page of article
ER  - 
